Uropartners – Prostate Center at the Glen

Specialties

At the Uropartners Prostate Center, our mission is to utilize the latest radiation therapy technology and our extensive experience to provide state of the art medical care while meeting the individual needs of our patients in a compassionate, friendly and respectful environment.

History

Established in 2008.

UroPartners is the only community-​based urology group in the Chicagoland area to have access to a new, breakthrough treatment for certain men with advanced prostate cancer who have limited treatment options. PROVENGE, an FDA-​approved vaccine, is designed to work differently than hormone therapy or chemotherapy. As an autologous cellular immunotherapy, this treatment uses cells from a patient’s own immune system to identify and attack prostate cancer cells.

Treatment with PROVENGE includes three doses given approximately two weeks apart. After three infusions, treatment with PROVENGE is complete. Potential reactions include fever and flu-​like symptoms, but the procedure is generally well-​tolerated.

For more information about this promising new treatment, talk with a UroPartners physician.

Meet the Manager

Dr. Parthiv M.

Manager

Parthiv Mehta

Medical Director

Education and Training

BS Industrial and Operations Engineering — University of Michigan„ MI,

MD/​MBA — University of Illinois, Chicago, IL, USA

Intern — Rush University Medical Center, Chicago, IL, USA

Resident — Radiation Oncology — Rush University Medical Center, Chicago, IL, USA

MS Medical Physics — Rush University Medical Center, Chicago, IL, USA

Certification

Board Certification in Radiation Oncology

The American Board of Radiology